---
figid: PMC5661117__JCMM-21-2663-g008
figtitle: Hippo pathway in mesothelioma cells
organisms:
- Homo sapiens
- Mus musculus
- Bos taurus
- Drosophila melanogaster
- Lareunionomyces loeiensis
- clinical samples
organisms_ner:
- Homo sapiens
- Mus musculus
- Bos taurus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC5661117
filename: JCMM-21-2663-g008.jpg
figlink: /pmc/articles/PMC5661117/figure/jcmm13182-fig-0008/
number: F8
caption: Diagram of the Hippo pathway in mesothelioma cells. Activated NF2 turns on
  Hippo kinase activity. With the genetic inactivation of Hippo kinases, YAP enters
  the cell nucleus instead of being phosphorylated, and promotes Hippo downstream
  gene transcription, cell proliferation and metastasis. Verteporfin disrupts the
  formation of the YAP–TEAD complex by specific binding to YAP and changing its conformation,
  thereby blocking the transcription of downstream genes (such as CTGF and AREG),
  then inhibiting the mesothelioma cell proliferation and metastasis. RhoA/ROCK signaling
  enhances YAP activity through inhibiting LATS1/2 and other undefined pathways. Rho/ROCK
  inhibitor GSK269962A prevents the activation of YAP by Rho/ROCK.
papertitle: Targeting YAP in malignant pleural mesothelioma.
reftext: Wen‐Qian Zhang, et al. J Cell Mol Med. 2017 Nov;21(11):2663-2676.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9481273
figid_alias: PMC5661117__F8
figtype: Figure
redirect_from: /figures/PMC5661117__F8
ndex: a6645b5f-def5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5661117__JCMM-21-2663-g008.html
  '@type': Dataset
  description: Diagram of the Hippo pathway in mesothelioma cells. Activated NF2 turns
    on Hippo kinase activity. With the genetic inactivation of Hippo kinases, YAP
    enters the cell nucleus instead of being phosphorylated, and promotes Hippo downstream
    gene transcription, cell proliferation and metastasis. Verteporfin disrupts the
    formation of the YAP–TEAD complex by specific binding to YAP and changing its
    conformation, thereby blocking the transcription of downstream genes (such as
    CTGF and AREG), then inhibiting the mesothelioma cell proliferation and metastasis.
    RhoA/ROCK signaling enhances YAP activity through inhibiting LATS1/2 and other
    undefined pathways. Rho/ROCK inhibitor GSK269962A prevents the activation of YAP
    by Rho/ROCK.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NF2
  - LATS1
  - LATS2
  - SAV1
  - RASSF1
  - RASSF2
  - RASSF3
  - RASSF4
  - RASSF5
  - RASSF6
  - RASSF7
  - RASSF8
  - RASSF9
  - RASSF10
  - ROCK1
  - ROCK2
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - MST1
  - STK4
  - STK3
  - CXCL10
  - MOB4
  - MOB1A
  - SGMS1
  - MOB1B
  - YAP1
  - CCN2
  - AREG
  - TEAD1
  - TEAD2
  - TEAD3
  - TEAD4
  - Nf2
  - Lats1
  - Lats2
  - Sav1
  - Rho
  - Rhod
  - Ea2
  - Mst1
  - Stk4
  - Stk3
  - Cxcl10
  - Mobq1
  - Mob1a
  - Yap1
  - Ccn2
  - Areg
  - Mer
  - wts
  - sav
  - Rassf
  - Rok
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - Mst57Dc
  - Mst57Db
  - Mst57Da
  - mst
  - hpo
  - Mob2
  - mats
  - yki
  - sd
  - nf2b
  - lats1
  - lats2
  - sav1
  - rnd2
  - mst1
  - mob1bb
  - ccn2a
  - ccn2b
  - areg
---
